IL139965A0 - Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism - Google Patents
Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolismInfo
- Publication number
- IL139965A0 IL139965A0 IL13996599A IL13996599A IL139965A0 IL 139965 A0 IL139965 A0 IL 139965A0 IL 13996599 A IL13996599 A IL 13996599A IL 13996599 A IL13996599 A IL 13996599A IL 139965 A0 IL139965 A0 IL 139965A0
- Authority
- IL
- Israel
- Prior art keywords
- methylerythrose
- inhibitors
- inhibit
- active compounds
- lipid metabolism
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000037356 lipid metabolism Effects 0.000 title 1
- 230000037353 metabolic pathway Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19828097A DE19828097A1 (en) | 1998-06-24 | 1998-06-24 | Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| DE19843279 | 1998-09-22 | ||
| PCT/EP1999/004360 WO1999066875A2 (en) | 1998-06-24 | 1999-06-23 | Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139965A0 true IL139965A0 (en) | 2002-02-10 |
Family
ID=26047010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13996599A IL139965A0 (en) | 1998-06-24 | 1999-06-23 | Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1100510A2 (en) |
| JP (1) | JP2002518418A (en) |
| CN (1) | CN1348374A (en) |
| AU (1) | AU752714B2 (en) |
| CA (1) | CA2334645A1 (en) |
| IL (1) | IL139965A0 (en) |
| PL (1) | PL345513A1 (en) |
| SK (1) | SK19612000A3 (en) |
| TR (1) | TR200003783T2 (en) |
| WO (1) | WO1999066875A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100724004B1 (en) | 1998-04-14 | 2007-06-04 | 교와 학꼬 고교 가부시키가이샤 | Searching for substances with antibacterial or herbicidal activity |
| WO2015127259A1 (en) * | 2014-02-23 | 2015-08-27 | Fmc Corporation | Use of 3-isoxazolidinones compounds as selective herbicides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4330529A (en) * | 1978-02-15 | 1982-05-18 | Fujisawa Pharmaceutical Co., Ltd. | Antibacterial composition |
| JPS6064991A (en) * | 1983-09-17 | 1985-04-13 | Fujisawa Pharmaceut Co Ltd | Cephalexin-fosmidomycin salt and its preparation |
| US4846872A (en) * | 1986-08-11 | 1989-07-11 | Fujisawa Pharmaceutical Co., Ltd. | Herbicide |
| JPH05163150A (en) * | 1991-05-13 | 1993-06-29 | E R Squibb & Sons Inc | Suppressant/remedy against atherromatous arteriosclerosis |
| CA2080158A1 (en) * | 1991-10-11 | 1993-04-12 | Scott A. Biller | Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof |
-
1999
- 1999-06-23 CN CN99809991A patent/CN1348374A/en active Pending
- 1999-06-23 SK SK1961-2000A patent/SK19612000A3/en unknown
- 1999-06-23 CA CA002334645A patent/CA2334645A1/en not_active Abandoned
- 1999-06-23 AU AU46155/99A patent/AU752714B2/en not_active Ceased
- 1999-06-23 WO PCT/EP1999/004360 patent/WO1999066875A2/en not_active Ceased
- 1999-06-23 EP EP99929309A patent/EP1100510A2/en not_active Withdrawn
- 1999-06-23 IL IL13996599A patent/IL139965A0/en unknown
- 1999-06-23 PL PL99345513A patent/PL345513A1/en unknown
- 1999-06-23 TR TR2000/03783T patent/TR200003783T2/en unknown
- 1999-06-23 JP JP2000555562A patent/JP2002518418A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU4615599A (en) | 2000-01-10 |
| SK19612000A3 (en) | 2001-08-06 |
| WO1999066875A2 (en) | 1999-12-29 |
| PL345513A1 (en) | 2001-12-17 |
| CN1348374A (en) | 2002-05-08 |
| AU752714B2 (en) | 2002-09-26 |
| EP1100510A2 (en) | 2001-05-23 |
| JP2002518418A (en) | 2002-06-25 |
| WO1999066875A3 (en) | 2000-09-14 |
| TR200003783T2 (en) | 2001-06-21 |
| CA2334645A1 (en) | 1999-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103707A3 (en) | Formulation of stable oxalyplatinum solution | |
| HUP0103464A3 (en) | Prodrugs of proton pump inhibitors and pharmaceutical compositions containing them | |
| AU4217499A (en) | Composition having therapeutic and/or nutritionally active substituent | |
| IL139321A0 (en) | Methods and compositions for modulating lipid metabolism | |
| HUP0105089A3 (en) | Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles | |
| TW370888U (en) | Structure of roller stand of roller skate | |
| HUP0101461A3 (en) | Novel pyridazine derivatives and drugs containing the same as the active ingredient | |
| HUP0003705A3 (en) | Analgesic compositions comprising anti-epileptic compounds and methods of using same | |
| IL137928A0 (en) | Dietary control of arachidonic acid metabolism | |
| IL123232A0 (en) | Medicament for inhibiting glucose metabolism deterioration | |
| EG24225A (en) | Solid lipid formulations | |
| NO20011459D0 (en) | Genes in the biosynthesis pathway of 1-deoxy-D-xylulose | |
| IL140667A0 (en) | Compositions containing at least one active substance having an influence on the levels of lipids in the blood | |
| PL349393A1 (en) | Sulphonyloxazolamines as therapeutic active ingredients | |
| AU2002328402A1 (en) | Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient | |
| IL139965A0 (en) | Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway and inhibitors of lipid metabolism | |
| HUP9802716A3 (en) | Pharmaceutical composition of analgesic activity | |
| AU5682900A (en) | Combination of mtp inhibitors and active agents that influence the metabolism and use thereof in medicaments | |
| HUP0102705A3 (en) | Alpha-amino acid phenyl ester derivatives and their use and pharmaceutical compositions comprising them | |
| AU6104498A (en) | Active composition for combating the effects of the cold and cosmetic product containing this composition | |
| TW394074U (en) | Improved structure of in-line roller-skates | |
| TW410558U (en) | Improved structure of shoelace | |
| AU2002361078A1 (en) | Markers for sugar/lipid metabolic disorders and utilization thereof | |
| TW355395U (en) | Secure structure of leggings for in-line skates | |
| GB9805675D0 (en) | Preparation of solid lipid compositions |